Masamichi Kimura

Safety, Tolerability, and Preliminary Efficacy of the Anti-Fibrotic Small Molecule PRI-724, a CBP/β-Catenin Inhibitor, in Patients with Hepatitis C Virus-related Cirrhosis: A Single-Center, Open-Label, Dose Escalation Phase 1 Trial

Kiminori Kimura, Akemi Ikoma, Maki Shibakawa et al. · EBioMedicine · 2017 · 100 citations · Full text

Restoration of myelin formation by a single type of myelin basic protein in transgenic shiverer mice.

Masamichi Kimura, Masahiro Sato, Akira Akatsuka et al. · Proceedings of the National Academy of Sciences · 1989 · 99 citations · Full text

Transgenic Shiverer Mice, Genetics, Compact Myelin Formation +18

Safety, tolerability, and anti-fibrotic efficacy of the CBP/β-catenin inhibitor PRI-724 in patients with hepatitis C and B virus-induced liver cirrhosis: An investigator-initiated, open-label, non-randomised, multicentre, phase 1/2a study

Kiminori Kimura, Tatsuya Kanto, Shinji Shimoda et al. · EBioMedicine · 2022 · 49 citations · Full text

Cronkhite-Canada syndrome associated with a rectal cancer and adenomatous changes in colonic polyps

Yosei Katayama, Masamichi Kimura, Mitsuru Konn · The American Journal of Surgical Pathology · 1985 · 46 citations

Cronkhite-canada Syndrome, Tumoral Pathology, Gastrointestinal Oncology +14

Pharmacologic patient management in pediatric dentistry: an update.

Braham Rl, Bogetz Ms, Masamichi Kimura · PubMed · 1994 · 45 citations

Pharmacology, Pediatrics, Patient Safety +14